Cases
A 32-year-old nulligravida Hispanic female was referred
to our department with complaints of general malaise, abdominal distention, loss of appetite, diffuse abdominal
pain and difficulty breathing that had worsened over the
last few days. She was known to have endometriosis that
was diagnosed at the time of an exploratory laparotomy
due to massive haemorrhagic ascites performed two years
before. She was started on oral contraceptives at that time
with poor response and was subsequently treated with
monthly 3.75 mg leuprolide IM (Lupron®) but she selfdiscontinued the treatment due to the desire to conceive.
The patient provided consent for publication of the case
report. The IRB was consulted and the IRB committee at
Hospital Pedro Mallo, Buenos Aires, Argentina deemed
this work exempt of approval.
Initial imaging with ultrasound and computed tomography (CT) scan revealed a large amount of intraperitoneal
fluid. A paracentesis was performed that obtained 5 litres
of thick bloody peritoneal fluid with a red blood cell count
of >50000/µL that was negative for bacteria or malignant
cells. The patient had symptomatic relief and was discharged
home after the procedure. She then returned eight days later
complaining of recurrence of the same symptoms. A repeat
ultrasound was performed along with magnetic resonance
imaging (MRI), which revealed massive ascites (Figes .1 , 2 ).
She was taken to the operating room for diagnostic laparoscopy and drainage of the hemoperitoneum. Upon entry of
the peritoneal cavity, a large amount of bloody peritoneal
fluid was identified. We removed ten litres of hemoperitoneum ( Fig .3 ). Extensive pelvic adhesions with complete
obliteration of surgical planes was noted ( Fig .4 ). The pelvis was described as “frozen” due to encapsulating peritonitis that prevented the creation of surgical planes ( Fig .5 ).
Multiple peritoneal biopsies were taken which revealed endometriotic implants ( Fig .6 ). The patient had an uneventful
postoperative recovery and was treated with the gonadotropin-releasing hormone (GnRH) agonist triptorelin (3.75 mg
intramuscular injection prior to discharge. At three months
of the postoperative course, the patient was asymptomatic
without recurrence of the disease.
A large amount of intraperitoneal fluid is visualized on computed
tomography (CT) of the abdomen and pelvis.
Massive ascites with small intestine floating inside the peritoneal
cavity visualized on transabdominal ultrasound.
Bloody ascites filling the abdominopelvic cavity. Note necrotic
omental adhesions on the anterior abdominal wall.
Note the complete obliteration of the vesicouterine space. The
uterus is encapsulated from dense inflammatory plastic peritonitis and
densely adheres to the pelvic side walls.
The liver is encapsulated by a dense parietal peritoneal inflammation. The liver is densely adherent to the anterior abdominal wall and the
gallbladder is not visualized.
Peritoneal biopsy confirming the diagnosis of endometriosis. The
endometriosis glands with periglandular endometriotic stroma that contain blood vessels are visualized.
Intro
Endometriosis is characterized by endometrial glands
and stroma outside the uterine cavity. Endometriosis is a
common condition that occurs in 6-10% of all reproductive
age women ( 1 - 3 ). This number increases to approximately
40% in women with infertility and nearly 75% in women
with complaints of chronic pelvic pain ( 4 , 5 ). The pathogenesis of endometriosis is still debated. A well-founded
theory postulates that it could be caused by retrograde
menstruation of hormone-sensitive endometrial cells and
tissues, which implant on peritoneal surfaces and cause an
inflammatory response ( 6 ). The most common complaints
associated with endometriosis are dysmenorrhea and pelvic
pain; however, patients often present without pain and only
with complaints of infertility, or there is an incidental finding of an ovarian mass on imaging ( 7 ). One exceedingly
rare, and interesting, presentation is haemorrhagic ascites.
Since its first description in 1954 by Dr. Brews, less than
100 cases of haemorrhagic ascites associated with endometriosis have been documented ( 8 ).
This article aims to present a case of a 32 year-old
woman who presented with recurrent haemorrhagic ascites. We will discuss the patient’s clinical course and surgical findings. A comprehensive review of the literature
on medical/surgical management of patients with this rare
finding will be presented.
Discussion
Massive ascites associated with endometriosis is extremely rare with less than 100 cases described in the literature ( 9 ). Endometriosis is a common challenging condition of reproductive-age women. The spectrum of the
disease ranges from asymptomatic to complete debilitation, which requires both aggressive surgical and medical
intervention. As stated above, the most common presenting symptoms of endometriosis are dysmenorrhea and
pelvic pain. Our case of haemorrhagic ascites represents
an incredibly rare complication associated with endometriosis. Patients with haemorrhagic ascites typically present with weeks to months of increasing abdominal pain,
anorexia/weight loss, abdominal pain and dysmenorrhea.
This presentation often leads to a workup for malignancy
as ovarian cancer was the suspected diagnosis in more
than half of the patients who presented with haemorrhagic
ascites ( 8 ).
While the majority of patients with haemorrhagic ascites present with a gradual onset of symptoms, reports
of acute onset of symptoms have been published. A 2013
case report described a 27-year-old who presented with a
one day onset of neck and flank pain, abdominal distention, light-headedness and palpitations. She was initially
stable, but progressively decompensated and required
transfusion of numerous units of packed red blood cells.
Ultimately, a diagnostic paracentesis was performed and
4.5 litres of grossly bloody ascitic fluid was removed ( 10 ).
Our patient who presented with an acute recurrence following drainage via paracentesis provided evidence of
how quickly the hemoperitoneum can accumulate.
Patients with haemorrhagic ascites often pose a difficult diagnostic dilemma on initial presentation. The different diagnosis must include large haemorrhagic ovarian
cyst rupture, ovarian cancer, ectopic pregnancy, endometriosis, Meigs’ syndrome, trauma, or other processes that
could cause large hemoperitoneum. If necessary, initial
stabilization measures with IV fluids and possible transfusion of blood products should be performed. As this presentation is so rare, no agreed upon workup is in place, but
should be focused on ruling out the more common causes
of hemoperitoneum. In a review of the literature, laboratory analyses that include complete blood count (CBC),
basic metabolic panel (BMP), urine pregnancy and Ca-
125 were typically performed, along with basic imaging
with either ultrasound, CT scan or MRI ( 8 ). Choice of
imaging is often physician dependent; however, MRI is
being used more frequently in evaluation for patients with
this presentation ( 11 ).
Haemorrhagic ascites has been treated both medically
and surgically. Medical management was attempted in
97% of patients with the use of hormonal therapy (e.g.,
GnRH agonist, danazol, progesterone, combination oral
contraceptive pills or a combination of these) ( 8 ). These
medications aim to inhibit ovarian functions and have
been well documented to successfully treat endometriosis. Although medical management was attempted, 89%
of patients ultimately underwent a surgical procedure ( 8 ).
The average volume of ascites was 4470 ± 2625 mL ( 12 ).
A review of numerous case reports showed that patients
underwent a variety of surgical procedures, which varied
from exploratory laparotomy with excision of an adnexal
mass, total abdominal hysterectomy, oophorectomy, ovarian wedge biopsy, lysis of adhesions, or a combination of
these. Newer case reports have also been published that
show successful management via a laparoscopic approach,
and one via diagnostic and therapeutic paracentesis ( 9 , 10 ,
13 ). Improvements were seen with both medical and surgical management; however, as in our patient, recurrence
is possible. The most successful treatments were bilateral
salpingo-oophorectomy or ovarian suppression therapy.
Both treatments had no recurrence of ascites ( 12 ).
The exact cause of haemorrhagic ascites in patients with
endometriosis is unknown. It has been suggested that the
ascites is caused by a ruptured endometrioma or by exudation of widespread pelvic endometriosis. However, Ussia
et al. ( 12 ) reported that endometriomas were only seen in
65% of cases, and that widespread superficial pelvic endometriosis was only associated with a minimal increase
in peritoneal fluid and not with massive ascites. They
have stated that the pathophysiology is ovarian in nature
and due to excessive ovarian transudation (e.g., similar to
Meigs’ syndrome and Pseudo-Meigs’ syndrome). Meigs’
syndrome is based on the triad of an ovarian fibroma,
pleural effusion and ascites with resolution of symptoms
after resection of the fibroma. Pseudo-Meigs’ syndrome is
associated with a benign pelvic mass and a typical rightsided pleural effusion without ascites ( 14 , 15 ). Their case
is strengthened by a 50% recurrence rate in the setting
of unilateral oophorectomy or cystectomy compared to
no recurrences when a bilateral oophorectomy was performed. Patients placed on ovarian suppression therapy
with a GnRH agonist also had no recurrence during the
time they were taking the medication.
Management needs to take into account a patient’s
age, surgical history, medical history and future fertility
plans. In patients who have no desire for future fertility
and desire definitive surgical treatment, a bilateral salpingo-oophorectomy would be most effective. Subtotal
surgical management (e.g., unilateral oophorectomy or
cystectomy) alone should be avoided as the recurrence
rate is high. Medical management with GnRH agonists
are proven to be highly effective and should be used with
a patient who desires future fertility, and for those who
want to avoid surgical intervention.
Conclusions
Haemorrhagic ascites is a poorly understood and rare
manifestation of pelvic endometriosis. The differential
diagnosis includes a variety of benign conditions, but
malignant pathology must be ruled out. There are no
specific protocols for the treatment of this rare condition. Current theories regarding the pathophysiology
point to the ovary and excessive ovarian transudation.
Management therefore involves surgical removal of
bilateral ovaries or medical management with ovarian
suppression. Patients who desire future fertility should
be managed with a GnRH agonist. Clinicians should
consider endometriosis in the differential diagnosis on
female patients of reproductive age who present with
haemorrhagic massive ascites.